Invention Grant
US09556275B2 Combination therapy using anti-C-met antibody and anti-ang-2 antibody
有权
使用抗C-met抗体和抗Ang-2抗体的联合治疗
- Patent Title: Combination therapy using anti-C-met antibody and anti-ang-2 antibody
- Patent Title (中): 使用抗C-met抗体和抗Ang-2抗体的联合治疗
-
Application No.: US14244709Application Date: 2014-04-03
-
Publication No.: US09556275B2Publication Date: 2017-01-31
- Inventor: Yun Ju Jeong , Kyung Ah Kim , Kyung Eun Kim , Chungho Kim
- Applicant: Samsung Electronics Co., Ltd.
- Applicant Address: KR Suwon-si
- Assignee: SAMSUNG ELECTRONICS CO., LTD.
- Current Assignee: SAMSUNG ELECTRONICS CO., LTD.
- Current Assignee Address: KR Suwon-si
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: KR10-2013-0036506 20130403
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; C07K16/22
Abstract:
A method for inhibiting angiogenesis and treating angiogenesis related diseases comprising administering an anti-c-Met antibody or an antigen-binding fragment thereof, and an anti-Ang-2 antibody or an antigen-binding fragment thereof, in combination simultaneously or sequentially; as well as related compositions and methods.
Public/Granted literature
- US20140302039A1 COMBINATION THERAPY USING ANTI-C-MET ANTIBODY AND ANTI-ANG-2 ANTIBODY Public/Granted day:2014-10-09
Information query
